Aptar Pharma Launch Disease Management Platform & Other Supplier News

Here’s what was new in the world of medical device suppliers during the week of October 16.

Katie Hobbins, Managing Editor

October 20, 2022

4 Slides

Aptar Pharma, a drug delivery and active materials science solutions and services company, recently announced the launch of a new disease management platform to help support patients in their treatment journey. The platform will let care teams access real-time remote data monitoring to track a patients treatment adherence. Additionally, patients can access remote patient diagnostic features, electronic patient reported outcomes, virtual care and telehealth solutions, system and trigger tracking, as well as educational content and videos.

“With this new platform, we are accelerating the pace of change for digital healthcare solutions,” said Sai Shankar, president of Aptar Digital Health.” Aptar Digital Health’s goal is to enhance patient experiences by providing continuous support and decentralized care. Our new offer consolidates our expertise in the field by proposing a solution that responds favorably to patient needs at each stage of their journey.”

About the Author(s)

Katie Hobbins

Managing Editor, MD+DI

Katie Hobbins is managing editor for MD+DI and joined the team in July 2022. She boasts multiple previous editorial roles in print and multimedia medical journalism, including dermatology, medical aesthetics, and pediatric medicine. She graduated from Cleveland State University in 2018 with a bachelor's degree in journalism and promotional communications. She enjoys yoga, hand embroidery, and anything DIY. You can reach her at [email protected].

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like